Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepat

Authors

Aldo Grefhorst (ORCID: https://orcid.org/0000-0003-1761-9494)
Quinten J. J. Augustijn (ORCID: https://orcid.org/0009-0006-9969-930X)
Peter Suenaert (ORCID: https://orcid.org/0000-0003-4810-0337)
Jos F. M. L. Seegers (ORCID: https://orcid.org/0000-0002-6092-9298)
Joanne Verheij (ORCID: https://orcid.org/0000-0003-1283-630X)
Ismail Sahin Gül
Koen Wortelboer (ORCID: https://orcid.org/0000-0002-3582-0127)
Willem M. de Vos (ORCID: https://orcid.org/0000-0002-0273-3166)
Hilde Herrema (ORCID: https://orcid.org/0000-0002-0112-6348)
Pleun de Groen (ORCID: https://orcid.org/0009-0008-4604-2755)
Adriaan Georgius Holleboom (ORCID: https://orcid.org/0000-0002-2911-2917)
Max Nieuwdorp

Institutions

Amsterdam UMC Location University of Amsterdam (NL)
Amsterdam University of the Arts (NL)
Amsterdam University Medical Centers (NL)
Vrije Universiteit Amsterdam (NL)
University of Amsterdam (NL)
Wageningen University & Research (NL)

Publication Details

Journal: BMJ Open
Published: 2025-01-01
DOI: https://doi.org/10.1136/bmjopen-2024-088290
Citations: 5
Primary Topic: Gut microbiota and health
Type: article
Field-Weighted Citation Impact: 4.03

Funders

ZonMw
Ministry of Economic Affairs
Topconsortium voor Kennis en Innovatie

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepat

Aldo Grefhorst, Quinten J. J. Augustijn, Peter Suenaert, Jos F. M. L. Seegers et al.

Jan 1, 2025

5 citations

BMJ Open

Gut microbiota and health

4.03

article

Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepat

Aldo Grefhorst, Quinten J. J. Augustijn, Peter Suenaert, Jos F. M. L. Seegers, Joanne Verheij, Ismail Sahin Gül, Koen Wortelboer, Willem M. de Vos, Hilde Herrema, Pleun de Groen, Adriaan Georgius Holleboom, Max Nieuwdorp

January 1, 2025article en

5 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 15(1)

Amsterdam UMC Location University of Amsterdam (NL), Amsterdam University of the Arts (NL), Amsterdam University Medical Centers (NL), Vrije Universiteit Amsterdam (NL), University of Amsterdam (NL), Wageningen University & Research (NL)

ZonMw, Ministry of Economic Affairs, Topconsortium voor Kennis en Innovatie

Good health and well-being

Openalex Percentile: Top 7%

Gut microbiota and health

4.03

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.